摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one | 1456623-99-6

中文名称
——
中文别名
——
英文名称
(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one
英文别名
(3aR,4R,9S,11aS,E)-4-heptyl-9-hydroxy-2,2-dimethyl-7,8,9,11a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]oxecin-6(4H)-one;(3aR,4R,9S,10E,11aS)-4-heptyl-9-hydroxy-2,2-dimethyl-3a,4,7,8,9,11a-hexahydro-[1,3]dioxolo[4,5-c]oxecin-6-one
(3aR,4R,9S,10E,11aS)-4-heptyl-3a,4,7,8,9,11a-hexahydro-9-hydroxy-2,2-dimethyl-6H-[1,3]dioxolo[4,5-c]oxecin-6-one化学式
CAS
1456623-99-6
化学式
C19H32O5
mdl
——
分子量
340.46
InChiKey
KDEFQBVNCUPVNQ-ZXZQLWFOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Carbohydrate-Based Approach for the Total Synthesis of Xyolide
    作者:Debendra Mohapatra、D. Reddy、Dnyaneshwar Karhale、Jhillu Yadav
    DOI:10.1055/s-0033-1339896
    日期:——
    We have achieved a total synthesis of xyolide, a bioactive nonenolide, by following a carbohydrate-based approach starting from d -(–)-ribose. The key reactions involved epoxide opening with a long-chain aliphatic Grignard reagent, Yamaguchi esterification, and a ring-closing-metathesis reaction. The longest linear sequence was nine steps and the overall yield was 30%.
    通过从 d -(-)-核糖开始,采用基于碳水化合物的方法,我们已经实现了木内酯(一种生物活性壬烯醇内酯)的全合成。关键反应包括环氧化物与长链脂肪族格氏试剂的开环、山口酯化和闭环复分解反应。最长的线性序列为 9 步,总产率为 30%。
  • Asymmetric synthesis of naturally occurring nonenolide xyolide through cross metathesis and macrolactonization reaction
    作者:Rohan Kalyan Rej、Anuvab Jana、Samik Nanda
    DOI:10.1016/j.tet.2014.02.072
    日期:2014.4
    Asymmetric total synthesis of xyolide, a small ring macrolide is presented in this article. The synthesis is achieved through an 'E' selective cross metathesis (CM) reaction between two appropriate fragments followed by lactonization by Shiina method. One of the fragments containing 7S,8S,9R stereocenters of xyolide is accessed from n-nonanal by adopting an organocatalytic asymmetric alpha-aminooxylation, Z-selective Ando olefination, and substrate directed dihydroxylation reaction. The other fragments containing 4S stereocenter was prepared by ME-DKR (metal enzyme combined dynamic kinetic resolution) method. (C) 2014 Elsevier Ltd. All rights reserved.
  • Stereoselective total synthesis of xyolide
    作者:B.V. Subba Reddy、P. Sivaramakrishna Reddy、B. Phaneendra Reddy、J.S. Yadav、Ahamad Al Khazim Al Ghamdi
    DOI:10.1016/j.tetlet.2013.08.038
    日期:2013.10
    A stereoselective total synthesis of xyolide is described employing MacMillan α-hydroxylation, Steglich esterification, and ring closing metathesis as key steps. The use of organocatalytic MacMillan α-hydroxylation to construct two of the chiral centers of the xyolide makes this approach attractive.
    描述了使用MacMillanα-羟基化,Steglic酯化和闭环复分解为关键步骤的二甲苯甲酸酯的立体选择性全合成。使用有机催化MacMillanα-羟基化来构建二氧内酯的两个手性中心使该方法具有吸引力。
  • A Stereoselective Total Synthesis of Xyolide, a Natural Bioactive Nonenolide
    作者:Lingaiah Maram、Biswanath Das
    DOI:10.1002/hlca.201400291
    日期:2015.5
    A stereoselective total synthesis of xyolide, a naturally occurring bioactive nonenolide, has been accomplished. The acid fragment of the molecule has been prepared from D‐mannitol and the alcohol fragment from (2Z)‐but‐2‐ene‐1,4‐diol. The synthesis involves the coupling of these two fragments using the Yamaguchi esterification protocol, followed by intramolecular ring‐closing methathesis. The diastereoisomeric
    已经完成了自然存在的生物活性壬烯内酯二甲酸酯的立体选择性全合成。该分子的酸片段是由D-甘露醇制备的,而醇片段是由(2 Z)-丁-2-烯-1,4-二醇制备的。合成过程涉及使用Yamaguchi酯化方案将这两个片段偶联,然后进行分子内闭环置换。通过采用Mitsunobu酯化反应,非对映异构醇片段也已用于该合成中。
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine